D

Diffusion Pharmaceuticals Inc
NASDAQ:CRVO

Watchlist Manager
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
Watchlist
Price: 6.99 USD -3.98% Market Closed
Market Cap: 64.7m USD

Profitability Summary

Diffusion Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Diffusion Pharmaceuticals Inc

Margins Comparison
Diffusion Pharmaceuticals Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
64.7m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.2B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Diffusion Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Diffusion Pharmaceuticals Inc
NASDAQ:CRVO
64.7m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.2B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.9B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.9B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Diffusion Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate